| 000 | 02420nam a2200325 a 4500 | ||
|---|---|---|---|
| 001 | ebr10641813 | ||
| 003 | CaPaEBR | ||
| 006 | m o u | ||
| 007 | cr cn||||||||| | ||
| 008 | 121010s2013 njuad sb 001 0 eng d | ||
| 010 | _z 2012032915 | ||
| 020 | _z9781118487471 (pbk.) | ||
| 020 | _z9781118511299 (e-book) | ||
| 040 |
_aCaPaEBR _cCaPaEBR |
||
| 035 | _a(OCoLC)831464032 | ||
| 050 | 1 | 4 |
_aHD9665.5 _b.L36 2013eb |
| 082 | 0 | 4 |
_a338.4/76151 _223 |
| 100 | 1 | _aLaMattina, John L. | |
| 245 | 1 | 0 |
_aDevalued and distrusted _h[electronic resource] : _bcan the pharmaceutical industry restore its broken image? / _cJohn L. LaMattina. |
| 260 |
_aHoboken, N.J. : _bWiley, _c2013. |
||
| 300 |
_aix, 125 p. : _bcol. ill. |
||
| 504 | _aIncludes bibliographical references and index. | ||
| 505 | 8 | _aMachine generated contents note: Introduction Part 1. "The 4 Secrets That Drug Companies Don't Want You to Know" Part 2. What Has Happened to R&D Productivity? a. Impact of Mergers b. Impact of FDA c. Impact of Payers Part 3. Challenges in Key Therapeutic Areas for Improving Health a. Cancer b. Diseases of the Brain c. Cardiovascular Disease d. Diabetes e. Bacterial Infections Part 4. Improving R&D Output a. View of Others b. Personal Vision Part 5. Restoring the Pharma Image Part 6. Final Thoughts. | |
| 520 |
_a"While the pharmaceutical industry can play an important role in converting the knowledge generated by the Human Genome Project into new medicines, it also faces a popular perception that it is simply out to make money by promoting unsafe medicines to an unsuspecting public. Written by former Pfizer president John LaMattina, this book addresses the progress that the industry has made in improving its abilities to measure both the risk and benefits of its new medicines, where the industry should invest its R&D resources, and how the industry can rehabilitate its image. Essential reading for pharmaceutical executives and professionals"-- _cProvided by publisher. |
||
| 533 |
_aElectronic reproduction. _bPalo Alto, Calif. : _cebrary, _d2015. _nAvailable via World Wide Web. _nAccess may be limited to ebrary affiliated libraries. |
||
| 650 | 0 |
_aPharmaceutical industry _xCorrupt practices. |
|
| 655 | 7 |
_aElectronic books. _2local |
|
| 710 | 2 | _aebrary, Inc. | |
| 856 | 4 | 0 |
_uhttp://site.ebrary.com/lib/rucke/Doc?id=10641813 _zAn electronic book accessible through the World Wide Web; click to view |
| 999 |
_c43327 _d43327 |
||